113 related articles for article (PubMed ID: 7935253)
21. [Growth hormone therapy in STH deficiency with immunologic deficiency and chromosome fragility].
Blümel P; Eibl M
Monatsschr Kinderheilkd; 1992 Apr; 140(4):223-6. PubMed ID: 1614448
[TBL] [Abstract][Full Text] [Related]
22. Short stature in Duchenne muscular dystrophy.
Rapaport D; Colletto GM; Vainzof M; Duaik MC; Zatz M
Growth Regul; 1991 Mar; 1(1):11-5. PubMed ID: 1842555
[TBL] [Abstract][Full Text] [Related]
23. [Final results of treatment with human growth hormone].
Job JC; Joab N; Toublanc JE; Canlorbe P
Arch Fr Pediatr; 1984; 41(7):477-82. PubMed ID: 6497556
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of short stature in children.
Martínez A; Coianis L; Heinrich JJ; Rodríguez A; Bergadá C
Helv Paediatr Acta; 1982; 37(6):563-70. PubMed ID: 7166490
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of the treatment with clonidine of short stature in children].
Casanova Bellido M; García Valderrama P; Rico de Cos S
An Esp Pediatr; 1989 Sep; 31(3):233-9. PubMed ID: 2631606
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of pituitary dwarfism with synthetic anabolic drugs].
Canlorbe P; Borniche P; Job JC; Bader JC
Ann Pediatr (Paris); 1969 Oct; 16(10):590-602. PubMed ID: 4311469
[No Abstract] [Full Text] [Related]
27. Growth hormone treatment of children with short stature increases insulin secretion but does not impair glucose disposal.
Walker J; Chaussain JL; Bougnères PF
J Clin Endocrinol Metab; 1989 Aug; 69(2):253-8. PubMed ID: 2666426
[TBL] [Abstract][Full Text] [Related]
28. The results of treatment of pituitary dwarfism with human growth hormone (author's transl).
Lenartowska I; Doliwa-Taborska J; Raczyńska B; Swiecicki A
Probl Med Wieku Rozwoj; 1972; 1():111-9. PubMed ID: 4680543
[No Abstract] [Full Text] [Related]
29. [Familial type of hypophyseal nanism. Apropos of 7 families in western Algeria].
Bey Omar F; Goossens M; Catbeh N; Duquesnoy P; Aguercif M
Helv Paediatr Acta; 1986 May; 41(1-2):31-40. PubMed ID: 3013806
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of hypophyseal nanism].
Tamburrano G; Grossi A
Minerva Endocrinol; 1990; 15(1):55-60. PubMed ID: 2274015
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry.
Wajnrajch MP; Gertner JM; Huma Z; Popovic J; Lin K; Verlander PC; Batish SD; Giampietro PF; Davis JG; New MI; Auerbach AD
Pediatrics; 2001 Apr; 107(4):744-54. PubMed ID: 11335753
[TBL] [Abstract][Full Text] [Related]
32. [Pretreatment growth rate and response to therapy with growth hormone (HGH)].
Cianfarani S; Spadoni GL; Scirè G; Manca Bitti ML; Galasso C; Benvenuti S; Rezza E; Boscherini B
Minerva Pediatr; 1987 Oct; 39(19):757-61. PubMed ID: 3325798
[No Abstract] [Full Text] [Related]
33. [Short stature due to a partial idiopathic deficiency of the growth hormone. The role of the TW2 method in assessing treatment with r-hGH].
Gibilisco G; De Liperi A; Giusti P; Tozzini A; Carafoli D; Celandroni A; Rolla M; Calderazzi A
Radiol Med; 1996 Mar; 91(3):181-6. PubMed ID: 8628927
[TBL] [Abstract][Full Text] [Related]
34. [Pituitary dwarfism. Our experience with human growth hormone treatment].
Sanz Moreno J; López-Linares M; Arrieta F; Ramos F; Herrera Pombo JL
Rev Clin Esp; 1981 Oct; 163(2):105-10. PubMed ID: 7330341
[No Abstract] [Full Text] [Related]
35. [The determination of bone age by the Greulich-Pyle and Tanner-Whitehouse methods as a basis for the growth prognosis of tall-stature girls].
Kahleyss S; Hoepffner W; Keller E; Willgerodt H
Padiatr Grenzgeb; 1990; 29(2):137-40. PubMed ID: 2352741
[TBL] [Abstract][Full Text] [Related]
36. [Familial short stature].
Igea García JM
An Esp Pediatr; 1988 Oct; 29 Suppl 35():6-8. PubMed ID: 3272841
[No Abstract] [Full Text] [Related]
37. Perceptions of self and short stature: effects of two years of growth hormone treatment.
Boulton TJ; Dunn SM; Quigley CA; Taylor JJ; Thompson L
Acta Paediatr Scand Suppl; 1991; 377():20-7; discussion 28. PubMed ID: 1785312
[TBL] [Abstract][Full Text] [Related]
38. A four-year, open-label, multi-center, randomized, two-arm study of Genotropin® in patients with idiopathic short stature: comparison of an individualized, target-driven treatment regimen to standard dosing of Genotropin® - analysis of two-year data.
Counts DR; Silverman LA; Geffner ME; Rajicic N; Hey-Hadavi J; Thornton PS; Wajnrajch MP;
Horm Res Paediatr; 2013; 80(4):242-51. PubMed ID: 24021297
[TBL] [Abstract][Full Text] [Related]
39. Constitutional delay influences the auxological response to growth hormone treatment in children with short stature and growth hormone sufficiency.
Gunn KC; Cutfield WS; Hofman PL; Jefferies CA; Albert BB; Gunn AJ
Sci Rep; 2014 Aug; 4():6061. PubMed ID: 25317732
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacologic treatment of constitutional short stature].
Zaccaria M
Minerva Endocrinol; 1990; 15(1):73-8. PubMed ID: 2274017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
